Publications by authors named "Elisa Rabadan Pejenaute"

Background: Identification of patients on admission to hospital with coronavirus infectious disease 2019 (COVID-19) pneumonia who can develop poor outcomes has not yet been comprehensively assessed.

Objective: To compare severity scores used for community-acquired pneumonia to identify high-risk patients with COVID-19 pneumonia.

Design: PSI, CURB-65, qSOFA, and MuLBSTA, a new score for viral pneumonia, were calculated on admission to hospital to identify high-risk patients for in-hospital mortality, admission to an intensive care unit (ICU), or use of mechanical ventilation.

View Article and Find Full Text PDF

It is unclear to which extent the higher mortality associated with hypertension in the coronavirus disease (COVID-19) is due to its increased prevalence among older patients or to specific mechanisms. Cross-sectional, observational, retrospective multicenter study, analyzing 12226 patients who required hospital admission in 150 Spanish centers included in the nationwide SEMI-COVID-19 Network. We compared the clinical characteristics of survivors versus non-survivors.

View Article and Find Full Text PDF
Article Synopsis
  • * The introduction of iPCSK9 medications allowed some patients to stop lipoapheresis while still maintaining healthy cholesterol levels.
  • * A case study of a 27-year-old male with Congenital Muscular Dystrophy and Heterozygous Familial Hypercholesterolemia showed successful treatment with alirocumab, reducing cLDL levels effectively after discontinuing lipoapheresis.
View Article and Find Full Text PDF